title: Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy.
authors.affiliation: Genzyme Corporation, Framingham, MA 01701-9322, USA. John.marshall@genzyme.com
authors.forename: John
authors.initials: J
authors.lastname: Marshall
authors.forename: Kerry Anne
authors.initials: KA
authors.lastname: McEachern
authors.forename: Wei-Lien
authors.initials: WL
authors.lastname: Chuang
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Hutto
authors.forename: Craig S
authors.initials: CS
authors.lastname: Siegel
authors.forename: James A
authors.initials: JA
authors.lastname: Shayman
authors.forename: Greg A
authors.initials: GA
authors.lastname: Grabowski
authors.forename: Ronald K
authors.initials: RK
authors.lastname: Scheule
authors.forename: Diane P
authors.initials: DP
authors.lastname: Copeland
authors.forename: Seng H
authors.initials: SH
authors.lastname: Cheng